Agency Information Collection Activities: Submission for OMB Review; Comment Request, 82032-82033 [2010-32708]
Download as PDF
<![CDATA[
srobinson on DSKHWCL6B1PROD with NOTICES
82032
Federal Register / Vol. 75, No. 249 / Wednesday, December 29, 2010 / Notices
MD 20993–0002, 301–796–9001, FAX:
301–847–8533, email:
kristine.khuc@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), and follow the
prompts to the desired center or product
area. Please call the Information Line for
up-to-date information on this meeting.
A notice in the Federal Register about
last minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Therefore, you should
always check the Agency’s Web site and
call the appropriate advisory committee
hot line/phone line to learn about
possible modifications before coming to
the meeting.
Agenda: On March 8, 2011, the
committee will discuss new drug
application (NDA) 022–383, indacaterol
maleate (ARCAPTA NEOHALER), by
Novartis Pharmaceuticals Corp., for the
long-term once daily maintenance
bronchodilator treatment of airflow
obstruction in patients with chronic
obstructive pulmonary disease,
including chronic bronchitis and/or
emphysema.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before February 22, 2011.
Oral presentations from the public will
be scheduled between approximately 1
p.m. to 2 p.m. Those individuals
interested in making formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before February
VerDate Mar<15>2010
02:10 Dec 29, 2010
Jkt 223001
11, 2011. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by February 14, 2011.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Kristine T.
Khuc at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act
(5 U.S.C. app. 2).
Dated: December 21, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2010–32735 Filed 12–28–10; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. chapter 35). To request a copy of
the clearance requests submitted to
OMB for review, e-mail
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
paperwork@hrsa.gov or call the HRSA
Reports Clearance Office on (301) 443–
1129.
The following request has been
submitted to OMB for review under the
Paperwork Reduction Act of 1995:
Proposed Project: Ryan White HIV/
AIDS Program Allocation and
Expenditure Forms (OMB No. 0915–
0318)—[Extension]
The Ryan White HIV/AIDS Program
Allocation and Expenditure Reports will
enable the Health Resources and
Services Administration’s HIV/AIDS
Bureau to track spending requirements
for each program as outlined in the
legislation. Grantees funded under Parts
A, B, C, and D of the Ryan White HIV/
AIDS Program (codified under Title
XXVI of the Public Health Service Act)
would be required to report financial
data to HRSA at the beginning and end
of their grant cycle.
All parts of the Ryan White HIV/AIDS
Program specify HRSA’s responsibilities
in the administration of grant funds.
Accurate allocation and expenditure
records of the grantees receiving Ryan
White HIV/AIDS Program funding are
critical to the implementation of the
legislation and thus are necessary for
HRSA to fulfill its responsibilities.
The forms would require grantees to
report on how funds are allocated and
spent on core and non-core services,
and on various program components,
such as administration, planning,
evaluation, and quality management.
The two forms are identical in the types
of information that are collected.
However, the first report would track
the allocation of the award at the
beginning of the grant cycle and the
second report would track actual
expenditures (including carryover
dollars) at the end of the grant cycle.
The primary purposes of these forms
are to (1) provide information on the
number of grant dollars spent on various
services and program components, and
(2) oversee compliance with the intent
of Congressional appropriations in a
timely manner. In addition to meeting
the goal of accountability to the
Congress, clients, advocacy groups, and
the general public, information
collected on these reports is critical for
HRSA, state and local grantees, and
individual providers for the evaluation
of the effectiveness of these programs.
The response burden for grantees is
estimated as:
E:\FR\FM\29DEN1.SGM
29DEN1
82033
Federal Register / Vol. 75, No. 249 / Wednesday, December 29, 2010 / Notices
Number of
grantee
respondents
Program under which grantee is funded
Part
Part
Part
Part
Part
Part
Responses
per grantee
Total
responses
Hours to
complete
each form
Total hours
A ...................................................................................
B ...................................................................................
A MAI ...........................................................................
B MAI ...........................................................................
C ...................................................................................
D ...................................................................................
56
59
56
59
361
90
2
2
2
2
2
2
112
118
112
118
722
180
8
12
4
4
7
7
896
1416
448
472
5054
1260
Total ..............................................................................
681
........................
1,362
........................
9,546
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this Federal
Register Notice to the desk officer for
HRSA, either by e-mail to
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. Please direct all
correspondence to the ‘‘attention of the
desk officer for HRSA.’’
Dated: December 22, 2010.
Robert Hendricks,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2010–32708 Filed 12–28–10; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
srobinson on DSKHWCL6B1PROD with NOTICES
National Institute of Dental and
Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Dental and
Craniofacial Research Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Mar<15>2010
02:10 Dec 29, 2010
Jkt 223001
Name of Committee: National Advisory
Dental and Craniofacial Research Council.
Date: January 24, 2011.
Open: 8:30 a.m. to 11:30 a.m.
Agenda: Report to the Director, NIDCR.
Place: National Institutes of Health,
Building 31C, 31 Center Drive, 6th Floor,
Conference Room 10, Bethesda, MD 20892.
Closed: 1 p.m. to Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31C, 31 Center Drive, 6th Floor,
Conference Room 10, Bethesda, MD 20892.
Contact Person: Alicia J. Dombroski, PhD,
Director, Division of Extramural Activities,
Natl. Inst. of Dental and Craniofacial
Research, National Institutes of Health,
Bethesda, MD 20892.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcr.nih.gov/about, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: December 21, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–32746 Filed 12–28–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel. Application of ‘‘Omics’’
Technologies in Tissue Samples.
Date: January 18, 2011.
Time: 9:30 a.m. to 10:45 a.m.
Agenda: To review and evaluate contract
proposals.
Place: NIEHS/National Institutes of Health
Sciences, Keystone Bldg., 530 Davis Drive,
Research Triangle Park, NC 27709.
(Telephone Conference Call).
Contact Person: RoseAnne M McGee,
Associate Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research and Training, Nat.
Institute of Environmental Health Sciences,
P.O. Box 12233, MD EC–30, Research
Triangle Park, NC 27709. (919) 541–0752.
mcgee1@niehs.nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel. High Throughput Screening
for Reactive Oxygen Species.
Date: January 18, 2011.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Nat. Inst. of Environmental Health
Sciences, Building 101, Rodbell Auditorium,
111 T.W. Alexander Drive, Research Triangle
Park, NC 27709. (Telephone Conference
Call).
Contact Person: RoseAnne M McGee,
Associate Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research and Training, Nat.
Institute of Environmental Health Sciences,
P.O. Box 12233, MD EC–30, Research
Triangle Park, NC 27709. (919) 541–0752.
mcgee1@niehs.nih.gov.
Name of Commitee: National Institute of
Environmental Health Sciences Special
Emphasis Panel. In Vitro 3–D Tissue Models
for Toxicity Testing.
Date: January 18, 2011.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: NIEHS/National Institutes of Health,
Keystone Bldg., 530 Davis Drive, Research
Triangle Park, NC 27709. (Telephone
Conference Call).
Contact Person: RoseAnne M McGee,
Associate Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research and Training, Nat.
Institute of Environmental Health Sciences,
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 75, Number 249 (Wednesday, December 29, 2010)]
[Notices]
[Pages 82032-82033]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32708]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources and Services Administration
(HRSA) publishes abstracts of information collection requests under
review by the Office of Management and Budget (OMB), in compliance with
the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35). To request
a copy of the clearance requests submitted to OMB for review, e-mail
paperwork@hrsa.gov or call the HRSA Reports Clearance Office on (301)
443-1129.
The following request has been submitted to OMB for review under
the Paperwork Reduction Act of 1995:
Proposed Project: Ryan White HIV/AIDS Program Allocation and
Expenditure Forms (OMB No. 0915-0318)--[Extension]
The Ryan White HIV/AIDS Program Allocation and Expenditure Reports
will enable the Health Resources and Services Administration's HIV/AIDS
Bureau to track spending requirements for each program as outlined in
the legislation. Grantees funded under Parts A, B, C, and D of the Ryan
White HIV/AIDS Program (codified under Title XXVI of the Public Health
Service Act) would be required to report financial data to HRSA at the
beginning and end of their grant cycle.
All parts of the Ryan White HIV/AIDS Program specify HRSA's
responsibilities in the administration of grant funds. Accurate
allocation and expenditure records of the grantees receiving Ryan White
HIV/AIDS Program funding are critical to the implementation of the
legislation and thus are necessary for HRSA to fulfill its
responsibilities.
The forms would require grantees to report on how funds are
allocated and spent on core and non-core services, and on various
program components, such as administration, planning, evaluation, and
quality management. The two forms are identical in the types of
information that are collected. However, the first report would track
the allocation of the award at the beginning of the grant cycle and the
second report would track actual expenditures (including carryover
dollars) at the end of the grant cycle.
The primary purposes of these forms are to (1) provide information
on the number of grant dollars spent on various services and program
components, and (2) oversee compliance with the intent of Congressional
appropriations in a timely manner. In addition to meeting the goal of
accountability to the Congress, clients, advocacy groups, and the
general public, information collected on these reports is critical for
HRSA, state and local grantees, and individual providers for the
evaluation of the effectiveness of these programs.
The response burden for grantees is estimated as:
[[Page 82033]]
----------------------------------------------------------------------------------------------------------------
Number of Hours to
Program under which grantee is grantee Responses per Total complete each Total hours
funded respondents grantee responses form
----------------------------------------------------------------------------------------------------------------
Part A.......................... 56 2 112 8 896
Part B.......................... 59 2 118 12 1416
Part A MAI...................... 56 2 112 4 448
Part B MAI...................... 59 2 118 4 472
Part C.......................... 361 2 722 7 5054
Part D.......................... 90 2 180 7 1260
-------------------------------------------------------------------------------
Total....................... 681 .............. 1,362 .............. 9,546
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent within 30 days of this Federal
Register Notice to the desk officer for HRSA, either by e-mail to
OIRA_submission@omb.eop.gov or by fax to 202-395-6974. Please direct
all correspondence to the ``attention of the desk officer for HRSA.''
Dated: December 22, 2010.
Robert Hendricks,
Director, Division of Policy and Information Coordination.
[FR Doc. 2010-32708 Filed 12-28-10; 8:45 am]
BILLING CODE 4165-15-P
